top of page
Relations.
Working with leading institutions worldwide
Research & Innovation
Our technology is backed by extensive research and clinical validation
Developing novel biosensor patch system for psychiatric treatment. Notice how you feel and restore your emotional responses to those with unmet depression and anxiety symptoms overwhelm.
Diagnostic Solution
Continuous, precision, objective psychological arousal activation responses state assessment throughout the day.
Behavioral Change
Fluctuations spikes are monitored and managed through mental steps marked with rewards so patients can train for optimal behavioral responses.
Electrodermal Activity (EDA) and hormones monitoring has the potential to change mental health care, it directly influence your mental fluctuations starting with neuro-reactivity.
Developing novel biosensor patch interface to manage behavioral resilience response to those with unmet depression and anxiety agitation burden of symptoms; unlocking behavioral change.
Biosensor.
Actionable data for mental actions.
For Insurers
Byosen improves patient care and outcomes with precision monitoring reducing treatment costs.
For Healthcare Providers
Clinical management, assessment of mental states, precision neuroscience allow for intervention with information decision making.
For Patients
Data-Driven Mental Fluctuations Analysis. You use this product to feel notice how you feel and train to respond better.
We help monitor and manage symptoms crisis to tailor medication without stimulation and without creating new reactions. Complexity behavioral response habits management are some of the reasons that can lead slow-moving treatment, those at risk of medication treatment failure.
We use a combination of biomarkers and algorithms for early identification to find the right treatment. We minimise time spent in treatment identification and providers risk in prescribing the wrong medication. Conversational action steps feedback with actionable data for behavioral responses.
Foundational research
We have shown proof of principle to provide real-time monitoring of mental states indicators to transform our capacity to engage early identification management. In principle, they can provide specific and sensitive insight into disease emergence leading to early intervention, so that quality of life is improved while dramatically reducing healthcare cost.
Payers, providers and the federal government, are unable to make behavioral health risk more predictable and manageable which is driving costs, impacting patient ability to manage outcomes and adding care resources burden. We help insurances integrate biosensing intelligence feedback into care management programs and treatment delivery.
bottom of page